Related Experiment Videos

Unravelling multiple ligand-activation binding sites using RASSL receptors

Petrus J Pauwels¹

¹Centre d'Immunologie Pierre Fabre 5, Avenue Napoléon III-BP 497, 74164 Saint-Julien-en-Genevois Cedex, France. peter.pauwels@pierre-fabre.com

Trends in Pharmacological Sciences

|October 16, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial).

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2021

Determination of risks of lower adherence to CPAP treatment before their first use by patients.

Journal of health psychology·2020

Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool.

BMC health services research·2014

7th cancer scientific forum of theCancéropôle Lyon Auvergne Rhône-Alpes: March 20-21, 2012, Lyon, France.

mAbs·2012

Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists.

Naunyn-Schmiedeberg's archives of pharmacology·2006

Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways.

British journal of pharmacology·2006

See all related articles